Dr E Ann Yeh - Longer-term safety of B-cell therapies in MS
Longer-term safety of B-cell therapies in MS
Жүктеу.....
Пікірлер: 4
@demoskunk Жыл бұрын
Very interesting. Since Ocrevus is the only dmt currently available for PPMS, I'll have to continue taking my chances with it. Hopefully the BTK inhibitors get FDA approval soon.
@ernietollar40711 ай бұрын
Ocrevus didn't help my PPMS so I'm in Mexico for HSCT in 5 days (a treatment which is effective in rebooting the faulty immune system of many with MS with cyclophosphide. Rituxan is used after the chemo.)
Пікірлер: 4
Very interesting. Since Ocrevus is the only dmt currently available for PPMS, I'll have to continue taking my chances with it. Hopefully the BTK inhibitors get FDA approval soon.
Ocrevus didn't help my PPMS so I'm in Mexico for HSCT in 5 days (a treatment which is effective in rebooting the faulty immune system of many with MS with cyclophosphide. Rituxan is used after the chemo.)
@yasminsoliman9160
11 ай бұрын
HSCT is not beneficial in PPMS, unfortunate